Cancer Therapy Could Benefit from Chitosan-Based Nano-Prodrugs
| Date | 1st, Jun 2022 |
|---|---|
| Source | AZoNano - Nanotechnology Websites |
DESCRIPTION
Scientists have stated that polysaccharide-based nano-prodrug crosslinked by stimuli-responsive synergetic prodrugs exhibit great tumor selectivity, stability, and synergetic effect. As a result, such...